Anna Ljung
Fortune : 16 300 $ au 30/06/2026
Fortune : 16 300 $ au 30/06/2026
Anna Ljung currently works at Moberg Pharma AB, as Chief Executive Officer from 2019, Moberg Derma Incentives AB, as Chairman, Biosergen AB, as Chairman from 2024, Saniona AB, as Independent Director from 2018, and Saniona A, as Director.
Ms. Ljung also formerly worked at OncoZenge AB, as Chairman from 2020 to 2023, Advantice Health LLC (New Jersey), as Director, ADDvise Group AB, as Independent Director from 2022 to 2026, Mpj Otc AB, as Director, Athera Biotechnologies AB, as Chief Financial Officer from 2005 to 2006, and Lipopetide AB, as Chief Financial Officer from 2005 to 2006.
Ms. Ljung received her graduate degree from Stockholm School of Economics.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANIONA AB 0,01 % | 31/12/2024 | 12 033 ( 0,01 % ) | 16 300 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MOBERG PHARMA AB | Directeur Général | 15/05/2019 |
| SANA AB | Directeur/Membre du Conseil | 19/01/2018 |
| BIOSERGEN AB | Président | 14/06/2024 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Directeur/Membre du Conseil | - |
Moberg Derma Incentives AB | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ADDVISE GROUP AB | Directeur/Membre du Conseil | 16/02/2026 |
| ONCOZENGE AB | Président | 21/08/2023 |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Directeur Financier/CFO | 01/01/2006 |
Lipopetide AB | Directeur Financier/CFO | 01/01/2006 |
| ░░░░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
ADDvise Group AB
ADDvise Group AB Medical DistributorsDistribution Services Provides investment holdings in supplying equipment to healthcare and research facilities and provides laboratory furnishings, safety ventilation, climate rooms, clean rooms and laboratory apparatus to the pharmaceutical industry and life science research | Distribution Services |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advantice Health LLC (New Jersey)
Advantice Health LLC (New Jersey) Household/Personal CareConsumer Non-Durables Develops and markets skin health & wellness products | Consumer Non-Durables |
Moberg Pharma AB
Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Lipopetide AB | |
Mpj Otc AB
Mpj Otc AB Pharmaceuticals: OtherHealth Technology Manufactures and distributes therapeutic medicines and personal products | Health Technology |
Moberg Derma Incentives AB | |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national